Heart rate variability biofeedback in chronic disease management: A systematic review.

Autonomic function Chronic disease Heart rate variability biofeedback Non-pharmacological intervention Symptom management

Journal

Complementary therapies in medicine
ISSN: 1873-6963
Titre abrégé: Complement Ther Med
Pays: Scotland
ID NLM: 9308777

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 09 09 2020
revised: 08 06 2021
accepted: 08 06 2021
pubmed: 13 6 2021
medline: 25 11 2021
entrez: 12 6 2021
Statut: ppublish

Résumé

Heart rate variability biofeedback (HRVB) is a non-pharmacological intervention used in the management of chronic diseases. A systematic search was performed according to eligibility criteria including adult chronic patients, HRVB as main treatment with or without control conditions, and psychophysiological outcomes as dependent variables. In total, 29 articles were included. Reported results showed the feasibility of HRVB in chronic patients without adverse effects. Significant positive effects were found in various patient profiles on hypertension and cardiovascular prognosis, inflammatory state, asthma disorders, depression and anxiety, sleep disturbances, cognitive performance and pain, which could be associated with improved quality of life. Improvements in clinical outcomes co-occurred with improvements in heart rate variability, suggesting possible regulatory effect of HRVB on autonomic function. HRVB could be effective in managing patients with chronic diseases. Further investigations are required to confirm these results and recommend the most effective method.

Sections du résumé

BACKGROUND BACKGROUND
Heart rate variability biofeedback (HRVB) is a non-pharmacological intervention used in the management of chronic diseases.
METHOD METHODS
A systematic search was performed according to eligibility criteria including adult chronic patients, HRVB as main treatment with or without control conditions, and psychophysiological outcomes as dependent variables.
RESULTS RESULTS
In total, 29 articles were included. Reported results showed the feasibility of HRVB in chronic patients without adverse effects. Significant positive effects were found in various patient profiles on hypertension and cardiovascular prognosis, inflammatory state, asthma disorders, depression and anxiety, sleep disturbances, cognitive performance and pain, which could be associated with improved quality of life. Improvements in clinical outcomes co-occurred with improvements in heart rate variability, suggesting possible regulatory effect of HRVB on autonomic function.
CONCLUSIONS CONCLUSIONS
HRVB could be effective in managing patients with chronic diseases. Further investigations are required to confirm these results and recommend the most effective method.

Identifiants

pubmed: 34118390
pii: S0965-2299(21)00091-1
doi: 10.1016/j.ctim.2021.102750
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102750

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Claire Fournié (C)

Laboratoire IRISSE EA4075, UFR des Sciences de l'Homme et de l'Environnement, Université de la Réunion, Le Tampon, La Réunion, France. Electronic address: fournie.claire@gmail.com.

Florian Chouchou (F)

Laboratoire IRISSE EA4075, UFR des Sciences de l'Homme et de l'Environnement, Université de la Réunion, Le Tampon, La Réunion, France. Electronic address: florian.chouchou@univ-reunion.fr.

Georges Dalleau (G)

Laboratoire IRISSE EA4075, UFR des Sciences de l'Homme et de l'Environnement, Université de la Réunion, Le Tampon, La Réunion, France. Electronic address: georges.dalleau@univ-reunion.fr.

Teddy Caderby (T)

Laboratoire IRISSE EA4075, UFR des Sciences de l'Homme et de l'Environnement, Université de la Réunion, Le Tampon, La Réunion, France. Electronic address: teddy.caderby@univ-reunion.fr.

Quentin Cabrera (Q)

Service d'Hématologie Clinique, CHU Sud Réunion, Saint Pierre, La Réunion, France. Electronic address: quentin.cabrera@chu-reunion.fr.

Chantal Verkindt (C)

Laboratoire IRISSE EA4075, UFR des Sciences de l'Homme et de l'Environnement, Université de la Réunion, Le Tampon, La Réunion, France. Electronic address: chantal.verkindt@univ-reunion.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH